COPD (Chronic Obstructive Pulmonary Disease) Clinical Trials

A 24 week randomized, double-blind, chronic dosing, placebo controlled study group to assess the effect and safety of PT003, PT005, and PT001 in subjects with moderate to severe COPD.

A 52 week double-blind, placedbo controlled study to evaluate the effect of roflumilast on the exacerbation rate in patients with COPD.

Montana Medical Research is now enrolling a Clinical Research Trial for Chronic Obstructive Pulmonary Disease.

Patient Inclusion Criteria: Must be between 40-80 years old and able to give consent Must have current diagnosis of moderate to severe COPD Current or prior cigarette smoking history of ≥10 pack-years Subjects must have a qualified cardiovascular indication Subjects must meet Spirometry measurements at screening Compensation will be made ...

If you or a loved one has Chronic Obstructive Pulmonary Disease (COPD), you may be interested in this clinical research study. This study is testing the benefits of an investigational drug in reducing lung and heart complications in people with COPD. Individuals may qualify for this study if they: Have ...

Do you have COPD, also called emphysema or chronic bronchitis? Are you 40-80 years old? Are you a current or former cigarette smoker? You may qualify for a research study testing investigational drug to see if it can reduce complications in people with COPD. Call 706-258-4112.

We are currently participating in a study to assess the efficacy and safety of different doses of study medication in patients with moderate to severe chronic obstructive pulmonary disease, using an active control. Patient Inclusion Criteria: Diagnosed with COPD Current or past smoker Age 40 or older A history of ...

NeuroTrials Research is conducting a new study for an inhalant for patients with COPD (chronic obstructive bronchitis or emphysema). Qualified participants receive compensation for time and travel as well as study drug and study-related exams at no cost. Patient Inclusion Criteria: Age 40 and older Current or former smoker Otherwise ...

The purpose of this research study is to determine how safe and effective a combined investigational inhaled medication is when taken for a long period of time compared to taking the individual components of that drug in the treatment of patients with chronic obstructive pulmonary disease (COPD). This study is ...

This is a research study for chronic pulmonary disease (COPD). Subjects who meet the criteria at Screening and meet the randomization criteria at the end of a Run In period will then enter the treatment phase of the study. Participation could last from 7 to 15 weeks. The study will ...